OMN-6
- Generic Name
- OMN-6
A Clinical Trial to Assess the Safety and PK of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii Complex
Phase 2
Recruiting
- Conditions
- Hospital-acquired Bacterial PneumoniaVentilator-associated Bacterial Pneumonia
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-10-17
- Last Posted Date
- 2025-02-26
- Lead Sponsor
- Omnix Medical Ltd
- Target Recruit Count
- 54
- Registration Number
- NCT06087536
- Locations
- 🇮🇱
Omnix Medical Research Site, Rishon LeTsiyon, Israel
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath